Alpha 2.0
Login Register
» Authors » G Mitterbauer

G Mitterbauer

Explore the profile of G Mitterbauer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 556
Followers 0
Related Specialties
Hematology
Oncology
Orthopedics
Top 10 Co-Authors
K Lechner
C Mannhalter
I Schwarzinger
O A Haas
U Jaeger
P Knobl
P Kalhs
K Geissler
K Laczika
U Jager
Published In
Leukemia
Ann Hematol
Br J Haematol
Int J Sports Med
Leuk Lymphoma
Affiliations
Soon will be listed here.
Recent Articles
21.
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR
Keil F, Mitterbauer G, Chen X, Haas O, Kalhs P, Lechner K, et al.
Transfusion . 2001 Feb; 41(1):111-6. PMID: 11161255
Background: Autografting of normal stem cells mobilized after chemotherapy is increasingly used in chronic myeloid leukemia (CML). Thus, quantification of possible contamination of progenitor cell apheresis with breakpoint cluster region...
22.
Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALL
Edelhauser M, Raber W, Mitterbauer G, Mannhalter C, Lechner K, Fonatsch C
Cancer Genet Cytogenet . 2000 Dec; 122(2):83-6. PMID: 11106816
A unique variant Philadelphia translocation accompanied by the loss of the short arm of chromosome 9 in a 32-year-old female with common acute lymphoblastic leukemia (cALL) is described. Furthermore, supernumerary...
23.
The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls
Endler G, Lalouschek W, Exner M, Mitterbauer G, Haring D, Mannhalter C
Br J Haematol . 2000 Sep; 110(2):469-71. PMID: 10971410
Genetic risk factors play an important role in the aetiology of vascular diseases. The insertion/deletion polymorphism (4G/5G) in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene has...
24.
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)
Reiter E, Greinix H, Rabitsch W, Keil F, Schwarzinger I, Jaeger U, et al.
Ann Hematol . 2000 Aug; 79(7):374-7. PMID: 10965785
Structural rearrangements of the long arm of chromosome 3 involving bands 3q21 and 3q26 and leading either to a paracentric inversion inv (3)(q21q26) or a translocation between both homologous chromosomes--t(3;3)(q21q26)--...
25.
Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction
Mitterbauer G, Zimmer C, Pirc-Danoewinata H, Haas O, Hojas S, Schwarzinger I, et al.
Br J Haematol . 2000 Jul; 109(3):622-8. PMID: 10886213
We studied 210 unselected patients with acute myeloid leukaemia (AML) for MLL abnormalities. Twenty-seven patients (13%) with rearranged MLL genes were identified by means of Southern blot analysis. An MLL-AF6...
26.
Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA
Mannhalter C, Koizar D, Mitterbauer G
Clin Chem Lab Med . 2000 Jun; 38(2):171-7. PMID: 10834406
Reverse transcription polymerase chain reaction (RT-PCR) analysis is increasingly becoming part of the diagnostic and prognostic evaluation for hematologic and oncologic disorders. Currently, different RNA isolation methods are used in...
27.
Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation
Jager U, Bocskor S, Le T, Mitterbauer G, Bolz I, Chott A, et al.
Blood . 2000 May; 95(11):3520-9. PMID: 10828038
The human t(14;18) chromosomal translocation is assumed to result from illegitimate rearrangement between BCL-2 and D(H)/J(H) gene segments during V(D)J recombination in early B cells. De novo nucleotides are found...
28.
The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?
Exner M, Thalhammer R, Kapiotis S, Mitterbauer G, Knobl P, Haas O, et al.
Cytometry . 2000 May; 42(2):106-9. PMID: 10797447
The immunophenotypes of 12 acute promyelocytic leukemias (APL-M3; eight hypergranular, four microgranular) with documented PML-RAR-alpha fusion gene are presented. Bone marrow mononuclear cells were immunophenotyped using a panel of 20...
29.
Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)
Laczika K, Mitterbauer G, Weltermann A, Knobl P, Thalhammer-Scherrer R, Haas O, et al.
Leuk Lymphoma . 2000 Apr; 36(5-6):625-9. PMID: 10784408
The benefit of all-trans-retinoic acid (ATRA) in the front line therapy of acute promyelocytic leukemia (APL) is well established, but its role in postremission therapy and in the treatment of...
30.
Chronic myelogenous leukemia in chronic phase for 16 years: ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy
Fiegl M, Mitterbauer G, Weltermann A, Pirc-Danoewinata H, Jager U
Leuk Lymphoma . 2000 Mar; 35(3-4):409-13. PMID: 10706467
Philadelphia chromosome-positive chronic myelogenous leukemia was diagnosed in a now 37-year old woman 16 years ago. Induction therapy with hydroxyurea and busulphan led to hematological remission lasting for about 4...